Tauira kore utu mō te Paura Anti-Aging 1094-61-7 Beta Nmn Nicotinamide Mononucleotide OEM 99% Nmn
Kei a mātou ngā mīhini hanga tino matatau, ngā miihini me ngā kaimahi mātau me ngā tohunga, ngā pūnaha whakahaere kounga pai kua whakamanahia, me te tautoko hoki a te tīma hokohoko ngaio i mua/i muri i te hoko mō te tauira kore utu mō te Paura Anti-Aging 1094-61-7 Beta Nmn Nicotinamide Mononucleotide OEM 99% Nmn, ko tā mātou ariā tautoko he pono, he pukumahi, he pono, he auaha. Mā te āwhina, ka pai ake tā mātou whakapai ake.
Kei a mātou ngā mīhini hanga tino matatau, ngā miihini me ngā kaimahi mātau me ngā tohunga, he pūnaha whakahaere kounga pai kua whakamanahia, me te tīma hokohoko ngaio hoki e tautoko ana i mua/muri i te hoko.Haina Nmn me te Nicotinamide Mononucleotide, He nui te rahinga whakaputa, he kounga teitei, he tuku i te wā tika, ā, ka whakamanahia tō makona. E mihi ana mātou ki ngā pātai me ngā urupare katoa. E whakarato ana hoki mātou i te ratonga tari—e mahi ana hei kaihoko i Haina mō ā mātou kiritaki. Mēnā kei te hiahia koe ki tētahi o ā mātou hua, kei te hiahia rānei koe ki te whakatutuki i tētahi ota OEM, kaua e mangere ki te whakapā mai ki a mātou inaianei. Mā te mahi tahi me mātou ka penapena moni me te wā mōu.
Nō nā tata nei, he rongo pai kei te ao o te NMN – whai muri i te arotake pakari a te komiti ngaio o te whakahaere mana o te US Food and Drug Administration (FDA), kua whakaaetia ngā rauemi mata NMN o Shangke Biopharmaceutical (Shanghai) Co., Ltd. (e kiia nei ko "Shangke Bio") e te United States FDA. Mā te whakaaetanga NDI e whakaū ka taea te whakamahi mana i ngā rauemi mata NMN ki te hanga, te hoko me te whakatairanga i ngā tāpiringa kai i te United States, ā, ka kitea i te paetukutuku mana o te FDA hei rauemi mata tāpiringa kai hou, nama 1247.
Ko te FDA NDI te pūnaha tiwhikete tino nui i te mākete o Amerika. Mā te whiwhi i tēnei tiwhikete, ehara i te mea ko te haumaru me te kounga o ngā hua a Shangke Bio anake te tohu, engari he mea whai hua anō hoki mō te whanaketanga paerewa tonu o te umanga NMN mō te wā roa.
| Ingoa Matū | β-Nikotinami Mononukleotida |
| Ngā kupu taurite | NIKOTINAMIRA-1-IUM-1-BETA-D-RIBOFURANOSIDE 5′-PHOSPHATE |
| Tau CAS | 1094-61-7 |
| Taumaha ngota | 334.22 |
| Tātai Ngota | C11H15N2O8P |
| EINECS ingoa: | 214-136-5 |
| Te pūwāhi rewa | 166 °C (whakaheke) |
| pāmahana rokiroki | -20°C |
| te wairewatanga | DMSO (Paku, Wera), Methanol (Paku), Wai (Paku) |
| puka | Totoka |
| tae | Mā ki te Kōwhai |
| Merck | 13,6697 |
| BRN | 3570187 |
| Te pumau: | Tino hihiko |
| InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
| Tūemi Whakamātautau | Ngā Whakatakotoranga |
| Āhua | Paura tioata mā ki te mā-parauri |
| Te ihirangi konutai | ≤1% |
| Uara pH (100mg/ml) | 2.0~4.0 |
| Te parakore | ≥99.0% |
| Te nui o te wai | ≤1% |
| Ngā konganuku taumaha | <10ppm |
| Āheni | <0.5ppm |
| Ārahi | <0.5ppm |
| Merekurai | <0.1ppm |
| Kāmiuma | <0.5ppm |
| toenga whakarewa | Etanora≤1000ppm |
| Tapeke o ngā moroiti hauātea | <750cfu/g |
| Rewena me te Pokepokea | <25cfu/g |
| Ko te katoa o te koriform | ≤0.92MPN/g |
| E. Coli | Kino |
| Salmonella | Kino |
| Staph. Aureus | Kino |
| Whakamātautau (i runga i te pūtake waikore) | ≥99.0% |
| Te tere tātari | ≥95% |
| Kīanga papatipu | Pūrongo mō ngā mōhiohio |
Mōkihi:Pounamu, putea konumohe, 25kg/Pahu Kāri, kia rite rānei ki te hiahia o te kiritaki.
Āhuatanga Rokiroki:Rongoā ki roto i ngā ipu piripono, ātete ki te mārama, mō te rokiroki roa, rongoā ki te 2~8°C, ki raro iho rānei.
Ko te Nicotinamide Mononucleotide (NMN) he putanga auaha o te huaora B3, he takahanga kotahi te mua o te NAD+ (Nicotinamide Adenine Dinucleotide). Ko te NMN te whakaora NAD+ pūtau tuatahi kua whakamātauhia he whai hua ki te whakaora i ngā pūtau i roto i te tinana ora.
Ko te Nicotinamide Adenine Dinucleotide (NAD) tētahi o ngā ngota tino nui, tino whakamere hoki o te tinana. E hiahiatia ana mō te neke atu i te 500 ngā tauhohenga whākōkī, ā, e whai wāhi nui ana ki te whakahaere i te nuinga o ngā tukanga koiora nui (Ansari and Raghava, 2010). Engari, mā tēnei ka taea e tātou te ora hauora me te roa ake o te ora.
Kei te noho te Nicotinamide Adenine Dinucleotide (NAD) i roto i tōna āhua waikura (NAD+) i tōna āhua whakaiti rānei (NADH), he hononga matua ēnei o te maha o ngā oxireductases.
Ko SyncoZyems te tuatahi ki te whiwhi i te hinonga whakaputa rauemi mata kua whakaaetia e te FDA NDI NMN, e tohu ana i te mana o te FDA e whakaae ana ki te NMN hei momo rauemi hou ka taea te tīmata te whakaae me te whakaaetia mō ngā kai tāpiringa kai i te United States. Kei a mātou ngā mīhini hanga tino matatau, ngā miihini me ngā kaimahi whai wheako me te tohu, ngā pūnaha whakahaere kounga pai kua whakaaetia me te tīma hokohoko tohunga tautoko i mua/muri i te hoko mō te tauira kore utu mō te Paura Anti-Aging 1094-61-7 Beta Nmn Nicotinamide Mononucleotide OEM 99% Nmn, ko tā mātou ariā tautoko he pono, he pukumahi, he pono me te auaha. Mā te āwhina, ka pai ake tā mātou whakapai ake.
Tauira kore utu mōHaina Nmn me te Nicotinamide Mononucleotide, He nui te rahinga whakaputa, he kounga teitei, he tuku i te wā tika, ā, ka whakamanahia tō makona. E mihi ana mātou ki ngā pātai me ngā urupare katoa. E whakarato ana hoki mātou i te ratonga tari—e mahi ana hei kaihoko i Haina mō ā mātou kiritaki. Mēnā kei te hiahia koe ki tētahi o ā mātou hua, kei te hiahia rānei koe ki te whakatutuki i tētahi ota OEM, kaua e mangere ki te whakapā mai ki a mātou inaianei. Mā te mahi tahi me mātou ka penapena moni me te wā mōu.
